Doping with anabolic androgenic steroids (AAS): Adverse effects on non-reproductive organs and functions. (Q38587545)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26373946%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

title

Doping with anabolic androgenic steroids (AAS): Adverse effects on non-reproductive organs and functions (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26373946%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26373946%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

author name string

Elena Vorona

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26373946%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

language of work or name

1 reference

1 September 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26373946%20AND%20SRC:MED&resulttype=core&format=json

Reviews in Endocrine and Metabolic Disorders

24 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26373946%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26373946%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26373946%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

page(s)

199-211

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26373946%20AND%20SRC:MED&resulttype=core&format=json

Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement

24 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

Anabolic agents: recent strategies for their detection and protection from inadvertent doping

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

The global epidemiology of anabolic-androgenic steroid use: a meta-analysis and meta-regression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

Performance-enhancing drugs on the web: a growing public-health issue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

Anabolic ergogenic substance users in fitness-sports: a distinct group supported by the health care system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

A review of the chemistry, biological action, and clinical applications of anabolic-androgenic steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

Side effects of AAS abuse: an overview.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

Pubertal upregulation of erythropoiesis in boys is determined primarily by androgen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

Effects of graded doses of testosterone on erythropoiesis in healthy young and older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

Androgen receptor gene CAG repeat length and body mass index modulate the safety of long-term intramuscular testosterone undecanoate therapy in hypogonadal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

Testosterone action on erythropoiesis does not require its aromatization to estrogen: Insights from the testosterone and estrogen treatment of two aromatase-deficient men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

Safety aspects of androgen treatment with 5alpha-dihydrotestosterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

Is the haematopoietic effect of testosterone mediated by erythropoietin? The results of a clinical trial in older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

Testosterone induces erythrocytosis via increased erythropoietin and suppressed hepcidin: evidence for a new erythropoietin/hemoglobin set point

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

Anabolic‐Androgenic steroid abuse in weight lifters: Evidence for activation of the hemostatic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

Effects of oxandrolone, an anabolic steroid, on hemostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

Androgenic steroid effects on liver and red cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

Use of doping agents, particularly anabolic steroids, in sports and society

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

Doping and thrombosis in sports

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

Anabolic androgenic steroid-induced cardiomyopathy, stroke and peripheral vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

Anabolic steroids abuse-induced cardiomyopathy and ischaemic stroke in a young male patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

Dilated cardiomyopathy and acute liver injury associated with combined use of ephedra, gamma-hydroxybutyrate, and anabolic steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

Anabolic steroids, acute myocardial infarction and polycythemia: a case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

Anabolics and cardiomyopathy in a bodybuilder: case report and literature review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

Anabolic steroid-induced cardiomyopathy underlying acute liver failure in a young bodybuilder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

Heart lesions associated with anabolic steroid abuse: comparison of post-mortem findings in athletes and norethandrolone-induced lesions in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

Anabolic androgenic steroids abuse and cardiac death in athletes: morphological and toxicological findings in four fatal cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

Sudden unexpected death in a female fitness athlete, with a possible connection to the use of anabolic androgenic steroids (AAS) and ephedrine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

The impact of the CAG repeat polymorphism of the androgen receptor gene on muscle and adipose tissues in 20-29-year-old Danish men: Odense Androgen Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

Androgen receptor CAG and GGC polymorphisms in Mediterraneans: repeat dynamics and population relationships

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

Ethnic variation in allele distribution of the androgen receptor (AR) (CAG)n repeat

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

A cellular memory mechanism aids overload hypertrophy in muscle long after an episodic exposure to anabolic steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

Potential adverse effects of long-term testosterone therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

Rhabdomyolysis of the deltoid muscle in a bodybuilder using anabolic-androgenic steroids: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

Abuse of supraphysiologic doses of anabolic steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

Self-Reported Anabolic-Androgenic Steroids Use and Musculoskeletal Injuries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

Cardiovascular risk associated with testosterone-boosting medications: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

Testosterone therapy and cardiovascular risk: advances and controversies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

Side effects of anabolic androgenic steroids abuse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

Liver enzymes and lipid levels in patients with lipodermatosclerosis and venous ulcers treated with a prototypic anabolic steroid (stanozolol): a prospective, randomized, double-blinded, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

The effects of varying doses of T on insulin sensitivity, plasma lipids, apolipoproteins, and C-reactive protein in healthy young men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

Cardiac and Metabolic Effects of Anabolic-Androgenic Steroid Abuse on Lipids, Blood Pressure, Left Ventricular Dimensions, and Rhythm

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

Are the cardiac effects of anabolic steroid abuse in strength athletes reversible?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

Long-term anabolic androgenic steroid use is associated with increased atrial electromechanical delay in male bodybuilders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

Left ventricular wall thickening does occur in elite power athletes with or without anabolic steroid Use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

Anabolic steroid use in body builders: an echocardiographic study of left ventricle morphology and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

Effects of anabolic-androgenic steroids on weight-lifters' myocardium: an ultrasonic videodensitometric study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

The athlete's heart and hypertrophic cardiomyopathy: two conditions which may be misdiagnosed and coexistent. Which parameters should be analysed to distinguish one disease from the other?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

Anabolic androgenic steroid use is associated with ventricular dysfunction on cardiac MRI in strength trained athletes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

Myocardial scar detected by cardiovascular magnetic resonance in a competitive bodybuilder with longstanding abuse of anabolic steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

Testosterone induces apoptosis in cardiomyocytes by increasing proapoptotic signaling involving tumor necrosis factor-α and renin angiotensin system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

Inflammatory dilated cardiomyopathy (DCMI).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

Hepatotoxicity from anabolic androgenic steroids marketed as dietary supplements: contribution from ATP8B1/ABCB11 mutations?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

Androgen abuse in athletes: detection and consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

Distinct phenotype of hepatotoxicity associated with illicit use of anabolic androgenic steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

Multiple hepatic adenomas caused by long-term administration of androgenic steroids for aplastic anemia in association with familial adenomatous polyposis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

Hepatocellular adenomas associated with anabolic androgenic steroid abuse in bodybuilders: a report of two cases and a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

Sex hormones and risk of liver tumor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

Development of hepatocellular carcinoma associated with anabolic androgenic steroid abuse in a young bodybuilder: a case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

Testosterone-receptor positive hepatocellular carcinoma in a 29-year old bodybuilder with a history of anabolic androgenic steroid abuse: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

Use of androgens in patients with renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

Cholestatic jaundice, acute kidney injury and acute pancreatitis secondary to the recreational use of methandrostenolone: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

Caution for anabolic androgenic steroid use: a case report of multiple organ dysfunction syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

Potentially harmful advantage to athletes: a putative connection between UGT2B17 gene deletion polymorphism and renal disorders with prolonged use of anabolic androgenic steroids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

Genetic and phenotypic variation in UGT2B17, a testosterone-metabolizing enzyme, is associated with BMI in males

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

Anabolic androgenic steroids: a survey of 500 users

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

Anabolic-androgenic steroid use and psychopathology in athletes. A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

Clinical features of muscle dysmorphia among males with body dysmorphic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

Eating disorders and anabolic androgenic steroids in males--similarities and differences in self-image and psychiatric symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

Sexual orientation and anabolic-androgenic steroids in U.S. adolescent boys

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

Neuroprotective strategies in drug abuse-evoked encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

Neurotoxicity by synthetic androgen steroids: oxidative stress, apoptosis, and neuropathology: A review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

A retrospective 30-year follow-up study of former Swedish-elite male athletes in power sports with a past anabolic androgenic steroids use: a focus on mental health.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

Treatment of anabolic-androgenic steroid dependence: Emerging evidence and its implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

Multisubstance use as a feature of addiction to anabolic-androgenic steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

Anabolic androgenic steroids and violent offending: confounding by polysubstance abuse among 10,365 general population men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

National Athletic Trainers' Association position statement: anabolic-androgenic steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

Current implementation and future of the Athlete Biological Passport

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

Genes in sport and doping.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

Sex hormone receptor gene variation associated with phenotype in male hypertrophic cardiomyopathy patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

Bile acid nephropathy in a bodybuilder abusing an anabolic androgenic steroid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-015-9320-5

Anabolic androgenic steroids produce dose-dependant increase in left ventricular mass in power atheletes, and this effect is potentiated by concomitant use of growth hormone

21 January 2018

1 reference

12 December 2020

Methasteron-Associated Cholestatic Liver Injury: Clinicopathologic Findings in 5 Cases

1 reference

12 December 2020

Effects of long term supplementation of anabolic androgen steroids on human skeletal muscle

1 reference

12 December 2020

Contraceptive steroids influence the hemostatic activation state in healthy men.

1 reference

12 December 2020

Effect of testosterone enanthate on hematopoiesis in normal men

1 reference

12 December 2020

Anabolic steroid use as the possible precipitant of dilated cardiomyopathy

1 reference

12 December 2020

[Dilated cardiomyopathy in a user of anabolic steroids]

1 reference

12 December 2020

Effects of Anabolic-Androgenic Steroids on Muscular Strength

1 reference

12 December 2020

Bilateral deltoid myositis ossificans in a weightlifter using anabolic steroids

1 reference

12 December 2020

The Effect of Chronic Anabolic-Androgenic Steroid Use on Tp-E Interval, Tp-E/Qt Ratio, and Tp-E/Qtc Ratio in Male Bodybuilders

1 reference

12 December 2020

MECHANISMS IN ENDOCRINOLOGY: Medical consequences of doping with anabolic androgenic steroids: effects on reproductive functions

1 reference

12 December 2020

Evidence of altered cardiac electrophysiology following prolonged androgenic anabolic steroid use

1 reference

12 December 2020

[Cardiomyopathy associated with uncontrolled self medication of anabolic steroids]

1 reference

12 December 2020

Testosterone and other anabolic steroids as cardiovascular drugs.

1 reference

12 December 2020

[Cardiovascular side effects of anabolic-androgenic steroids]

1 reference

12 December 2020

Long term perturbation of endocrine parameters and cholesterol metabolism after discontinued abuse of anabolic androgenic steroids

1 reference

12 December 2020

Genetics of hypertrophic and dilated cardiomyopathy

1 reference

12 December 2020

Annual banned-substance review: analytical approaches in human sports drug testing

1 reference

12 December 2020

Effect of testosterone on the in vitro proliferation of bone marrow granulocyte-macrophage cells (CFU-GM). II. Observations in hypogonadal subjects

1 reference

12 December 2020

Is methyltestosterone no longer used therapeutically?

1 reference

12 December 2020

Metabolic and hormonal changes of severely burned children receiving long-term oxandrolone treatment

1 reference

12 December 2020

Cause and manner of death among users of anabolic androgenic steroids

1 reference

12 December 2020